title: Cyclin D1 gene amplification in proliferating haemangioma.
abstract: Cyclin D1 gene amplification has been reported to promote abnormal endothelial cell proliferation and angiogenesis; these findings constantly present in proliferating haemangiomas. The present study was conducted to evaluate cyclin D1 gene amplification by fluorescence in situ hybridization analysis in tissue biopsies of 22 proliferating haemangiomas from 20 infants. Two significant correlations of cyclin D1 gene amplification with the early onset and the duplication of proliferating haemangiomas have been observed. Moreover, a significant correlation (P< or =0.05) has been found between the treatment parameters of proliferating haemangiomas with the amplified versus the normal cyclin D1 gene. Proliferating haemangiomas with the amplified cyclin D1 gene required more frequent flashlamp pulsed dye laser treatment sessions at the maximum dosimetry and more frequent intralesional steroid injections at the maximum dose/injection but treatment outcomes were limited. The more frequent post-treatment complications among proliferating haemangiomas with cyclin D1 gene amplification might be attributable not only to the associated more aggressive natural course, but also to the higher treatment parameters needed for effective treatment. Within the limitations of the present study, cyclin D1 gene amplification was seen for the first time in proliferating haemangiomas. We have found that the amplification of the cyclin D1 gene can predict the more aggressive natural course of proliferating haemangiomas and the limited outcome and higher incidence of complications after non-excision treatment modalities. The present findings reflect the possible usefulness of antisense cyclin D1 to improve the therapeutic outcome of proliferating haemangiomas.
authors.affiliation: Department of Human Cytogenetics, Human Genetics and Genome Research Division, National Research Center, Cairo, Egypt.
authors.forename: Amal M
authors.initials: AM
authors.lastname: Mohamed
authors.forename: Tarek F
authors.initials: TF
authors.lastname: Elwakil
authors.forename: Ibrahim M
authors.initials: IM
authors.lastname: Taher
authors.forename: Mohamed M
authors.initials: MM
authors.lastname: Elbarbary
authors.forename: Hesham F
authors.initials: HF
authors.lastname: Kayed
authors.forename: Hassan A
authors.initials: HA
authors.lastname: Hussein
authors.forename: Ola M
authors.initials: OM
authors.lastname: Eid
mesh_terms: D001706:Biopsy; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism; D005260:Female; D005784:Gene Amplification; D019940:Genes, bcl-1; D006391:Hemangioma / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D053685:Laser Therapy; D008297:Male; D013256:Steroids / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D013256:Steroids; D019938:Cyclin D1